All Updates

All Updates

icon
Filter
Partnerships
Iktos partners with Italfarmaco to speed drug discovery breakthroughs with AI
AI Drug Discovery
Jun 18, 2024
This week:
Product updates
Nintendo ventures into MMOs with new Switch Online game playtest
Metaverse Experience Platforms
Yesterday
Product updates
HP releases texture library for 3D printing with CoreTechnologie 4D Additive
Additive Manufacturing
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Smart Factory
Oct 21, 2024
Product updates
xAI launches API for third-party developers to access Grok models
Foundation Models
Oct 21, 2024
Partnerships
Nava Benefits partners with OpenAI to launch AI-powered benefits assistant
Foundation Models
Oct 21, 2024
Product updates
IBM releases Granite 3.0 AI models for enterprise use
Foundation Models
Oct 21, 2024
Partnerships
Honeywell partners with Google to bring Gemini AI to industrial sector
Foundation Models
Oct 21, 2024
M&A
Inflection AI acquires Boundaryless for undisclosed sum to accelerate enterprise AI deployments
Foundation Models
Oct 21, 2024
Industry news
News Corp sues Perplexity AI for alleged copyright infringement
Generative AI Applications
Oct 21, 2024
Product updates
Haiper debuts new video generation model
Generative AI Applications
Oct 21, 2024
AI Drug Discovery

AI Drug Discovery

Jun 18, 2024

Iktos partners with Italfarmaco to speed drug discovery breakthroughs with AI

Partnerships

  • AI-powered medicinal research company Iktos and private global pharmaceutical company Italfarmaco have announced a collaboration to develop next-generation histone deacetylase (HDAC) inhibitors for a range of diseases, including those affecting the central nervous system. The terms and financial details of the agreement have not been disclosed.

  • The partnership aims to develop HDAC inhibitors using Iktos' AI-powered drug discovery platforms, Makya and Spaya. Italfarmaco will leverage its experience in epigenetics and HDAC inhibitors and Iktos' AI expertise to identify promising drug candidates faster and more efficiently.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.